Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BCRXBCRX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BIOCRYST PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 4.5M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $44.8M as of 2026-Q2. The position was increased (+90.9% shares). BCRX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$44.8M

Current Shares

4.5M

Total Value Change

+$35.1M

Total Shares Change

+3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+90.9%
$44.8M0.0%$10.00
46
2026-Q1
Decreased
2.3M
-26.9%
$22.3M0.0%$9.52
0
2025-Q4
Increased
3.2M
+18.5%
$25.1M0.0%$7.80
34
2025-Q3
Decreased
2.7M
-23.1%
$20.6M0.0%$7.59
0
2025-Q2
Increased
3.5M
+82.4%
$31.6M0.0%$8.96
44
2025-Q1
Increased
1.9M
+49.6%
$14.5M0.0%$7.50
39
2024-Q4
New
1.3M
-
$9.7M0.0%$7.52
38

Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used